DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Multiparametric modulation of magnetic transduction for biomolecular sensing in liquids
Electronic supplementary information (ESI) available. See DOI: https://doi.org/ 10.1039/d3nr06489a, The recent COVID19 pandemic has remarkably boosted the research on in vitro diagnosis assays to detect biomarkers in biological fluids. Specificity and sensitivity are mandatory for diagnostic kits aiming to reach clinical stages. Whilst the modulation of sensitivity can significantly improve the detection of biomarkers in liquids, this has been scarcely explored. Here, we report on the proof of concept and parametrization of a novel biosensing methodology based on the changes of AC magnetic hysteresis areas observed for magnetic nanoparticles following biomolecular recognition in liquids. Several parameters are shown to significantly modulate the transducing capacity of magnetic nanoparticles to detect analytes dispersed in saline buffer at concentrations of clinical relevance. Magnetic nanoparticles were bio-conjugated with an engineered recognition peptide as a receptor. Analytes are engineered tetratricopeptide binding domains fused to the fluorescent protein whose dimerization state allows mono- or divalent variants. Our results unveil that the number of receptors per particle, analyte valency and concentration, nanoparticle composition and concentration, and field conditions play a key role in the formation of assemblies driven by biomolecular recognition. Consequently, all these parameters modulate the nanoparticle transduction capacity. Our study provides essential insights into the potential of AC magnetometry for customizing biomarker detection in liquids., This work was partially funded by the Spanish State Research Agency (PCI2019-103600, CEX2020-001039-S, MDM-2017-0720, PID2019-111649RB-I00, PID2020-117080RB-C51, PID2020- 117080RB-C53, PID2019-111649RB-I00, PDC2021-120957-I00, PDC2022-133345-I00, and Hipernano, RED2018-102626-T, PTA2018-015076) and Comunidad de Madrid (PEJ-2017-AI/ BMD-7517, PEJ-2020-AI/IND-19394, NANOMAGCOST S2018/ NMT-4321). COST Actions CA17115 (MyWave) and CA17140 (Nano2Clinic) were also acknowledged. This work was partially supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie HeatnMof grant (GA No. 860942)., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PCI2019-103600
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-111649RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-117080RB-C51
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-117080RB-C53
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-111649RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PDC2021-120957-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PDC2022-133345-I00
DOI: http://hdl.handle.net/10261/358915, https://api.elsevier.com/content/abstract/scopus_id/85185188436
HANDLE: http://hdl.handle.net/10261/358915, https://api.elsevier.com/content/abstract/scopus_id/85185188436